A detailed history of Iron Triangle Partners LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Iron Triangle Partners LP holds 376,330 shares of AZN stock, worth $26.5 Million. This represents 4.48% of its overall portfolio holdings.

Number of Shares
376,330
Holding current value
$26.5 Million
% of portfolio
4.48%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$65.37 - $77.96 $24.6 Million - $29.3 Million
376,330 New
376,330 $27.7 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $3.41 Million - $4.09 Million
57,477 Added 15.13%
437,477 $28.9 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $21.2 Million - $25.5 Million
380,000 New
380,000 $25.2 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $16.2 Million - $19.1 Million
-300,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $16.7 Million - $18.2 Million
300,000 New
300,000 $18 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Iron Triangle Partners LP Portfolio

Follow Iron Triangle Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Triangle Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Iron Triangle Partners LP with notifications on news.